ArticleAnnals of surgical oncology2026

The Efficacy of Adjuvant EGFR-TKI Therapy for Stage IA Lung Adenocarcinoma with EGFR Mutations: A Retrospective Cohort Study.

Yaoxi Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.